US wholesale giant Costco launches a lawsuit against the Trump White House, alleging misuse of emergency powers to impose tariffs. The firm warns importers may never recover funds even if duties are ruled unlawful.
A new UK-US deal doubling spending on US medicines raises NHS funding fears. Experts warn of a 'problematic precedent' that could impact Australia and global healthcare systems.
The EU's 2035 ban on new petrol and diesel cars creates a significant challenge for Chinese-owned Volvo and Polestar. Discover the strategic shifts and potential tariffs impacting these Swedish brands.
The UK has secured a major three-year deal for zero US import tariffs on pharmaceuticals, safeguarding £5bn in annual exports and boosting life sciences investment. Read the full analysis.
The UK and US have agreed a landmark deal maintaining zero tariffs on pharmaceuticals, while the NHS commits to a 25% net price increase for new medicines. Explore the details and implications.
The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products, ensuring access to latest medical breakthroughs. Read the full details.
Millions of electric vehicle owners will pay extra £49 monthly from January as Ofgem raises energy price cap. Learn how to reduce charging costs.
US regulator FDA announces major overhaul of vaccine approval process following COVID-19 review. New protocols aim to strengthen public trust in immunisation programmes.
UK small businesses face holiday season crisis as Trump's tariffs threaten to derail Christmas sales. Discover how British entrepreneurs are fighting back.
Guardian readers across America reveal how rising prices and unemployment fears are forcing them to cut back on festive spending. Discover how economic uncertainty is changing holiday traditions.
On the eve of the budget, we assess the criticism facing Chancellor Rachel Reeves, her pitch to Labour MPs, and the potential for tax rises. Plus, a warning on China tariffs.
Novo Nordisk shares slumped over 10% after its Ozempic pill failed to slow Alzheimer's progression in major trials. Read the latest on the pharmaceutical giant's market struggles.
As Trump touts Walmart's cheap Thanksgiving deals, economists reveal a complex picture of holiday food prices affected by tariffs and inflation. Discover the full story.
High-level US officials head to Brussels to resolve sticking points in July's controversial tariff agreement. Key issues include steel levies and implementation delays.
Analysis of Trump's chaotic post-election affordability drive, revealing contradictions, magical thinking, and economic missteps. Discover the real impact on US voters.
US officials privately indicate potential delay in Trump's promised 100% semiconductor tariffs to avoid trade war with China and consumer price concerns. Full analysis.
UK ministers propose 25% increase in NHS drug cost-effectiveness thresholds to resolve investment row with pharmaceutical giants and boost life sciences sector.
Japan's economy contracts for first time in six quarters as US tariffs hammer exports. GDP falls 1.8% annualised amid global trade tensions. Discover the full impact.
US President Donald Trump has signed an executive order removing tariffs on Australian beef and other food imports. Australian officials welcome the decision, calling previous duties 'unjustified'.
Donald Trump has signed an executive order lowering tariffs on beef, coffee and bananas, marking a sharp policy reversal as concerns over rising costs grow. Explore the political implications.
American consumers face difficult choices as Trump's new tariffs and persistent cost of living pressures impact holiday shopping budgets. Discover how families are adapting.
American pasta lovers face potential shortages as Trump considers 107% tariffs on Italian imports. Celiac sufferers and pasta connoisseurs panic-buy favourite brands.
Global tax advisory market set to hit $64bn as Trump's trade policies and tariffs create unprecedented complexity, driving demand for specialist services. Discover the key growth sectors.
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
The US Supreme Court has agreed to hear a landmark case challenging Donald Trump's authority to impose sweeping tariffs, setting up a constitutional battle with global economic implications.
Danish pharmaceutical giant Novo Nordisk has cut its sales and profit forecasts for the second time in three months, sending shockwaves through the healthcare sector as demand for its blockbuster weight-loss drugs shows signs of slowing.
In a dramatic shift in trade policy, China removes tariffs on US soybeans as Microsoft reports staggering $237 billion market cap loss following cyber attack. Full market coverage.
The US Supreme Court hears landmark case challenging Trump's sweeping tariff authority, testing constitutional limits of presidential power in international trade.
In a dramatic fiscal shift, Canada's new Liberal government under Mark Carney unveils a budget adding tens of billions to the deficit, deploying massive spending to counter economic damage from Trump's tariffs.
Exclusive analysis reveals Donald Trump's sweeping plans to reshape American governance through executive orders targeting immigration, trade and federal institutions if he returns to the White House.